Biocon will undertake the development, manufacturing and supply of the drug product, and Biomm will be responsible for obtaining regulatory approval and commercialization in the Brazilian market
Sun Pharma's Dadra facility receives OAI status from US FDA
A significant proportion of healthcare professionals still tend to favor branded drugs
Total value of the supplies of FC will be US$ 2.773 million
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
Enhertu now has five approved indications with the latest in HER2-expressing (IHC 3+) metastatic cancers
The company plans to add 1700 beds by FY27 through the organic route
Reconfirms a relative bioavailability of 65 percent and significant savings when using DL-methionine
TriClip offers a remarkably safe, minimally invasive treatment option for patients in need of tricuspid valve repair but who are unable to withstand surgery
Subscribe To Our Newsletter & Stay Updated
